Thrombocytopenia
115 results
1 - 100
Antenatal interventions for fetomaternal alloimmune thrombocytopenia- Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
- Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
- Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
- Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours: Cochrane systematic review
- Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta‐analysis and systematic review
- Medical treatments for idiopathic thrombocytopenic purpura during pregnancy: Cochrane systematic review
- Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters
- Prophylactic platelet transfusions prior to surgery for people with a low platelet count
- Thrombopoietin mimetics for patients with myelodysplastic syndromes: Cochrane systematic review
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
- Heparin-bonded catheters for prolonging the patency of central venous catheters in children: Cochrane systematic review
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Early intravenous nutrition for the prevention of neonatal jaundice
- Ticlopidine versus oral anticoagulation for coronary stenting
- Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes: Cochrane systematic review
- Anticoagulants for people hospitalised with COVID‐19
- Radioisotopes for metastatic bone pain: Cochrane systematic review
- Heparin versus placebo for non‐ST elevation acute coronary syndromes
- Cyclophosphamide for treating rheumatoid arthritis
- Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
- Pegylated liposomal doxorubicin for first‐line treatment of epithelial ovarian cancer
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Anticoagulation for people with cancer and central venous catheters
- Linezolid versus vancomycin for skin and soft tissue infections
- Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease
- Comparison of a therapeutic‐only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders
- Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis
- Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
- Pentasaccharides for the treatment of deep vein thrombosis
- Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
- Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis
- A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
- Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters: Cochrane systematic review
- Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
- Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
- Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Heparin versus normal saline for patency of arterial lines
- Heparin for the treatment of thrombosis in neonates
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
- Interventions for atypical haemolytic uraemic syndrome
- Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
- Erythropoietin or darbepoetin for patients with cancer
- Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
- Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias
- Cooling for newborns with hypoxic ischaemic encephalopathy
- Interleukin 2 receptor antagonists for kidney transplant recipients: Cochrane systematic review
- Heparin for assisted reproduction
- Early introduction of lipids to parenterally‐fed preterm infants
- Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Parenteral anticoagulation in ambulatory patients with cancer
- Quinine for muscle cramps
- Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
- Bortezomib for the treatment of multiple myeloma: Cochrane systematic review
- Interferon alpha for chronic hepatitis D
- Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults